News FeedExperimental Crohn’s, MS Drug Carries Dangers
November 3, 2005 by admin · Leave a Comment
The potential side effects of a once-promising drug for multiple sclerosis and Crohn’s disease are of serious concern and may outweigh any potential benefit, researchers report.
A new study of the drug, natalizumab (Tysabri), found that while there was some positive response, one patient died from progressive multifocal leukoencephalopathy (PML), a brain infection. This is not the first time PML has surfaced in relation to Tysabri.
Read more
